Hepatotoxicity associated with dietary energy supplements: Use and abuse by young athletes

Annals of Hepatology

Volumn 11, Issue 4, 2012, Pages 564-569

  Avelar Escobar, Giovanni ^a   Méndez Navarro, Jorge ^a   Ortiz Olvera, Nayeli X ^a   Castellanos, Guillermo ^a   Ramos, Roberto ^a   Gallardo Cabrera, Víctor E ^a   Vargas Alemán, José de Jesús ^b   de León, Óscar Díaz ^a   Rodríguez, Elda V ^a   Dehesa Violante, Margarita ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Acute hepatitis; Cholestasis; Dietary supplements; Drug induced liver injury; Hepatotoxicity; Herbal medicine

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CARNITINE; COLCHICINE; COLESTYRAMINE; CREATINE; GROWTH FACTOR ATN; NO XPLODE; PERFORMANCE ENHANCING SUBSTANCE; PREDNISONE; RIBAVIRIN; SIMICARNITINA; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; BIOLOGICAL MARKER; NON PRESCRIPTION DRUG;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANOREXIA; ARTICLE; ASTHENIA; ATHLETE; BODY BUILDING; CASE REPORT; CHOLESTASIS; DIET SUPPLEMENTATION; ENERGY DRINK; EPIGASTRIC PAIN; FLUID INTAKE; HEPATITIS A; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; INFLAMMATORY INFILTRATE; INTRAHEPATIC CHOLESTASIS; JAUNDICE; LIVER BIOPSY; LIVER CELL DAMAGE; MALE; MUSCLE MASS; NAUSEA; PHYSICAL EXAMINATION; PHYSICAL PERFORMANCE; PRODUCT SAFETY; PRURITUS; SUBSTANCE ABUSE; TACHYCARDIA; TOXIC HEPATITIS; VOMITING; WEAKNESS; ACUTE DISEASE; ATHLETIC PERFORMANCE; BIOPSY; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ECHOGRAPHY; LIVER; LIVER FUNCTION TEST; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ACUTE DISEASE; ADOLESCENT; ATHLETES; ATHLETIC PERFORMANCE; BIOLOGICAL MARKERS; BIOPSY; CARNITINE; CHOLESTASIS; CREATINE; DIETARY SUPPLEMENTS; DRUG-INDUCED LIVER INJURY; HUMANS; LIVER; LIVER FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; NONPRESCRIPTION DRUGS; PERFORMANCE-ENHANCING SUBSTANCES;

EID: 84862014084     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31474-7     Document Type: Article

References (26)

1. Stickel F, Kessebohm K, Weiman R, Seitz K. Review of liver injury associated with dietary supplements. Liver Int 2011; 31(5): 595-605.
2. DesJardins M. Supplement use in the adolescent athlete. Current Sports Medicine Reports 2002; 1: 369-73.
3. Favreau JT, Ryu ML, Braunstein G, et al. Severe hepatotoxicity associated with dietary supplement LipoKinetix. Ann Intern Med 2002; 136: 590-5.
4. Di Luigi L. Supplements and the endocrine system in athletes. Clin Sports Med 2008; 27: 131-51.
5. Hardy ML. Dietary supplement use in cancer care: Help or Harm. Hematol Oncol Clin N Am 2008: 22: 581-617.
6. Stickel F, Droz S, Patsenker E, Bogli-Stuber K, Aebi B, Leib SL. Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subti lis. J Hepatol 2009; 50: 111-7.
7. Garcia-Cortes M, Borraz Y, Lucena MI, et al. Liver injury induced by natural remedies: an analysis of cases submitted to the Spanish Liver Toxicity Registry. Rev Esp Enferm Dig 2008; 100: 688-95.
8. Schoepfer AM, Engel A, Fattinger K, et al. Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J Hepatology 2007; 47: 521-6.
9. Fong TL, Klontz K, Canas-Coto A, et al. Hepatotoxicity due to hydroxycut: A case series. Am J Gastroenterol 2010; 105: 1561-6.
10. Sanchez W, Maple JT, Burgart LJ, Kamath PS. Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Mayo Clin Proc 2006; 81: 541-4.
11. Shah N, Zacharias I, Khettry U, Addhal N. Methasteron-Associatd Cholestatic Liver Injury: Clinicopathologic Findings in 5 cases. Clin Gastroenterol Hepatol 2008; 6: 255-8.
12. Pugh AJ, Barve AJ, Falkener K, Patel M, McClain CJ. Drug-Induced hepatotoxicity or drug-induced liver injury. Clin Liver Dis 2009; 13: 277-94.
13. Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. BrJ Clin Pharmacol 2008; 66: 758-66.
14. Teschke R. Hepatotoxicity by drugs and dietary supplements: safety perspectives on clinical and regulatory issues. Ann Hepatol 2009; 8: 184-95.
15. Scheuer PJ, Lefkowitch JH. Drugs and toxins. In: Liver Biopsy Intrepetation. 7th Ed. London UK: Elsevier & Saunders; 2006, p. 134-48.
16. Zimmerman HJ, Ishak KG. Hepatic injury due to drugs and toxins. In: MacSween RNM, Burt AD, Portmann BC (eds.). Pathology of the liver. 4th Ed. Edinburg: Churchill Livings tone; 2002, p. 621.
17. Aithal GP, Rawlins MD, Day CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol 2000; 33: 949-52.
18. Sleeper RB, Kennedy SM. Adverse reaction to a dietary supplement in an elderly patient. Ann Pharmacother 2003; 37: 83-6.
19. Magee CD, Moawad FJ, Moses F. NO-Xplode: a case of supplement-associated ischemic colitis. Mil Med 2010; 175: 202-5.
20. Prosser JM, Majlesi N, Chan GM, Olsen D, Hoffman RS, Nelson LS. Adverse effects associated with arginine a-keto-glutarate containing supplements. Hum Exp Toxicol 2009; 28: 259-62.
21. Wang JS, Tan N, Dhawan A. Significance of low or normal serum gamma glutamyl transferase level in infants with idiopathic neonatal hepatitis. Eur J Pediatr 2006; 165: 795-801.
22. Davit-Spraul A, Fabre M, Branchereau S, et al. ATP8B1 and ABCB11 analysis in 62 children with normal Gamma-glutamyl transferase progressive Familial intrahepatic cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology 2010; 51: 1645-55.
23. Diario Oficial de la Federación (DOF). Norma Oficial Mexi cana NOM-251-SSA1-2009. Prácticas de higiene para el proceso de alimentos, bebidas o suplementos alimenticios. 1 de marzo de 2010. Disponible en: http://www.dof.gob.mx/documentos/3980/salud/salud.htm [Retrieved: October 2011].
24. Comisión Federal para la protección contra riesgos sanita rios (COFEPRIS). Productos milagro, su regulación comer cial y publicitaria en Mexico. Disponible en: http://www.cofepris.gob.mx/work/sites/cfp/resources/LocalContent/402/1/b55.pdf [Retrieved: June 11, 2011].
25. Cofepris ordena retiros de más de 250 productos Milagro por publicidad engañosa. 14 de febrero 2011. Disponible en: http://www.cofepris.gob.mx/Notas%20Principales/2011/Documentos/PM.pdf [Retrieved: June 11, 2011].
26. Alerta Cofepris sobre el crecimiento de suplementos alimenticios para bajar supuestamente de peso. 26 de Agosto 2009. Disponible en: http://mymanuel.wordpress.com/2009/08/30/mexico-alerta-cofepris-sobre-el-crecimiento-de-suplementos-alimenticios-para-bajar-supuestamente-de-peso/ [Retrieved: June 11, 2011].